Drawing for INSTADERM DERMATOLOGY

USPTO serial 88175801

INSTADERM DERMATOLOGY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
IN, SUNG HYUN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INSTADERM DERMATOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eduard Kotlyarov, Jr.

EDUARD KOTLYAROV, JR. SEIBANE, KOTLYAROV, & ASSOCIATES PLLC4910 COMMUNICATION AVESUITE 200BOCA RATON, FL 33431

Goods and services

ClassDescriptionStatusFirst use
003Body and beauty care cosmetics; Cosmetic body care preparations, namely, body wraps, facials, and peels; Cosmetic body scrubs for the face, body. hands, and feet; Cosmetic creams for skin care; Cosmetic oils for the epidermis; Cosmetic preparations, namely, firming creams; Cosmetic nourishing creams; Cosmetic sun-tanning preparations; Cosmetics sold as an integral component of non-medicated skincare preparations; Skin conditioning creams for cosmetic purposesACTIVE—
005Dermatological pharmaceutical products; Dermatologicals; Gels, creams and solutions for dermatological use; Medicated dermatological preparations and substances; Medicated creams for treating dermatological conditions; Medicated lotions for treating dermatological conditions; Medicated ointments for treating dermatological conditions; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Topical dermatological preparations that treat insect bites and stingsACTIVE—
010Lasers for the cosmetic treatment of the face and skinACTIVE—
044Aesthetician services; Beauty analysis to determine cosmetics that are best suited to particular individuals; Cosmetic body care services in the nature of body wraps; Cosmetic face care services; Cosmetic hair removal by means of laser; Cosmetic laser treatment in the nature of hair and tattoo removal; Cosmetic skin care services; Cosmetic skin care services, namely, acne treatment, micro-needling, microdermabrasion, sclerotherapy, chemical peels, laser treatments, injectables, and fillers; Cosmetic analysis; Cosmetic body care services; Dermatologic laser removal of varicose veins, toenail fungus, spider veins, hair and tattoos; Dermatology services; Facial treatment services, namely, cosmetic peels; Health spa services, namely, cosmetic body care services; Medical clinic providing weight loss solutions, services and programs, nutrition counseling, hormone therapy, including, bioidentical hormone replacement, anti aging therapy, and natural hormone therapy, medical aesthetic procedures, including, laser hair removal, laser peels, botulinum toxin treatments, microdermabrasion, liposuction, vein treatments, vein therapy, cellulite treatments, body contouring treatments, injectable filler treatments, facials, and skin care; Medical spa services, namely, minimally and non-invasive cosmetic and body fitness therapies; Providing medical advice in the field of dermatology; Providing medical information in the field of dermatology; Providing a web site featuring medical information; Health spa services for health and wellness of the body and spirit, namely, providing massage, facial and body treatment services, cosmetic body care services; Performing non-invasive cosmetic medical procedures; Skin treatments, namely, the injection of dermal filling agents and neuromuscular blocking agents to reduce the appearance of facial lines and wrinklesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 31, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 31, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 21, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 19, 2020EX1GSOU EXTENSION 1 GRANTED—
Jan 19, 2020EXT1SOU EXTENSION 1 FILED—
Jan 19, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 27, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 27, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Apr 27, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 27, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 27, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 19, 2019ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 19, 2019PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 6, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 4, 2019ALIEASSIGNED TO LIE—
Feb 14, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 14, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Feb 14, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 14, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 14, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 6, 2019DOCKASSIGNED TO EXAMINER—
Nov 16, 2018MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 15, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 3, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance